the aid library

LIST OPTIONS

Filter

4223

Testen & COVID-19

Seitz, W.; and S. Mauder MEDBOX (2021) CC

04.März 2021 MEDBOX Issue Brief no. 10 Dieser Issue Brief gibt einen kurzen Überblick über Teststrategie, Testverfahren, Videos zur Handhabung und weiterführende Literatur.

A Concise Quality Control Guide on Essential Drugs and other Medicines

Jähnke, R.W.O. and Kornelia Dwornik (2021) CC

100 test methods for 100 active pharmaceutical ingredients For existing Minilab projects that want to replace old manuals or initiatives that want to start new projects, the new "Minilab Edition 2020" can be obtained at the preferential price of 50 € from our logistic partner Technologie Transfer... more

Tests physiques & Chromatographie sur couche mince

Jähnke, R.W.O. and Kornelia Dwornik (2021) CC

100 méthodes d'essai pour 100 principes pharmaceutiques actifs Pour les projets Minilab existants qui souhaitent remplacer les anciens manuels ou les initiatives qui veulent lancer de nouveaux projets, la nouvelle "Minilab Edition 2020" peut être obtenue au prix préférentiel de 50 € auprès d... more

Control Visual y Cromatografía en Capa Fina

Jähnke, R.W.O. and Kornelia Dwornik (2021) CC

100 métodos de ensayo para 100 principios activos farmacéuticos Para los proyectos Minilab existentes que quieran sustituir los manuales antiguos o las iniciativas que quieran iniciar nuevos proyectos, el nuevo "Minilab Edition 2020" puede obtenerse al precio preferente de 50 euros de nuestro soc... more

A Concise Quality Control Guide on Essential Drugs and other Medicines: COVID-19 Special Issue

Jähnke, R.W.O. and Kornelia Dwornik (2021) CC

Two test methods on dexamethasone tablets and injections

Control Visual y Cromatografía en Capa Fina: Edición especial de COVID-19

Jähnke, R.W.O. and Kornelia Dwornik (2021) CC

Dexametasona en comprimimidos Dexametasona inyectable

Tests physiques & Chromatographie sur couche mince : COVID-19 numeró spécial

Jähnke, R.W.O. and Kornelia Dwornik (2021) CC

deux méthodes d'essai sur les comprimés et les injections de dexaméthasone

Oncology Patient Navigation Training: Results of a Pilot Study in Nigeria

Chidebe, R.C.W., and M.L. Pratt-Chapman (2021) CC

Journal of Cancer Education https://doi.org/10.1007/s13187-020-01935-7

Population simulations of COVID-19 outbreaks provide tools for risk assessment and continuity planning

Bo Peng , Rowland W. Pettit, and Christopher I. Amos JAMIA Open (2021) CC

ABSTRACT Objectives: We developed COVID-19 Outbreak Simulator (https://ictr.github.io/covid19-outbreak-simulator/) to quantitatively estimate the effectiveness of preventative and interventive measures to prevent and battle COVID-19 outbreaks for specific populations.

Die elektronische Gesundheitskarte für Asylsuchende - Zusammenfassung der wissenschaftlichen Evidenz

A. W. Gold; Weis, J.; Janho, L; et al. Uni Heidelberg (2021) CC

Dieser Policy Brief fasst den bis Juni 2021 verfügbaren Wissensstand zu Auswirkungen der Einführung der elektronischen Gesundheitskarte (eGK) für Asylsuchende zusammen. Es werden empirische Erkentnisse zu den Auswirkungen auf die Inanspruchnahme von Gesundheitsleistungen, auf Gesundheitsoutcome... more

Community health workers’ efforts to build health system trust in marginalised communities: a qualitative study from South Africa

Watkins, J:W.; F. Griffiths, and J. Goudge BMJ Open (2021) C1

Community health workers (CHWs) enable marginalised communities, often experiencing structural poverty, to access healthcare. Trust, important in all patient–provider relationships, is difficult to build in such communities, particularly when stigma associated with HIV/AIDS, tuberculosis and now ... more

Changes in cardiovascular mortality in Chile during the COVID-19 pandemic

Chang, S.W.; P. Zitko, Á. Passi-Solar et al. Heart, BMJ journals (2021) C1

The COVID-19 pandemic has impacted regular cardiovascular healthcare access and delivery. Service utilisation has declined, and excess cardiovascular mortality has been reported in several countries. We aim to estimate excess cardiovascular deaths in Chile during 2020.

How to achieve the Sustainable Development Goals within planetary boundaries by 2050

O’Neill, D.W.; A.L: Fanning; W.F.Lamb; et al. (2018) C1

Cancer in sub-Saharan Africa
recommended

Ngwa, W.; et al. Lancet Oncology Commission (2022) C2

Lancet Oncol 2022; 23: e251–312Published OnlineMay 9, 2022 https://doi.org/10.1016/S1470-2045(21)00720-8 In sub-Saharan Africa (SSA), urgent action is needed to curb a growing crisis in cancer incidence and mortality. Without rapid interventions, data estimates show a major increase in cancer mo... more

Handlungsempfehlungen für die Erstellung von Hitzeaktionsplänen zum Schutz der menschlichen Gesundheit

Straff, W.; Mücke, H.G. et al. Umweltbundesamt (2017) CC

Die durch den Klimawandel verursachte globale Erwärmung hat in vielen Regionen der Welt, so auch in Deutschland, eine vermehrte Häufigkeit und Dauer von Hitzeereignissen zur Folge. Hitze kann den menschlichen Organismus gesundheitlich stark belasten und auch für das Gesundheitswesen können Hi... more

Global Burden of Human Mycetoma: A Systematic Review and Meta-analysis

Van de Sande, W. PLoS Neglected Tropical diseases (2013) CC

Mycetoma is a chronic infectious disease of the subcutaneous tissue with a high morbidity. This disease has been reported from countries between 30°N and 15°S since 1840 but the exact burden of disease is not known. It is currently unknown what the incidence, prevalence and the number of reported ... more

Clinical management of East African trypanosomiasis in South Africa: Lessons learned

Frean J., Sieling W., Pahad H. et al International Journal of Infectious Diseases (2018) C2

Background: East African trypanosomiasis is an uncommon, potentially lethal disease if not diagnosed and treated in a timely manner. South Africa, as a centre for emergency medical evacuations from much of sub-Saharan Africa, receives a high proportion of these patients, mostly tourists and expatria... more

Cardiovascular diseases in Tanzania: The burden of modifiable and intermediate risk factors

Roman, W.P.; Martin, H.D.; Sauli, E. et al. Journal of Xiangya Medicine (2019) CC

Tanzania, like other developing countries, is facing a higher burden of cardiovascular diseases (CVDs). The country is experiencing rapid growth of modifiable and intermediate risk factors that accelerate CVD mortality and morbidity rates. In rural and urban settings, cardiovascular risk factors suc... more

Cardiovascular diseases in Africa in the twenty-first century: Gaps and priorities going forward

Minja, N.W.; Nakagaayi, D.; Aliku, T. et al. Frontiers in Cardiovascular Medicine (2022) CC

In 2015, the United Nations set important targets to reduce premature cardiovascular disease (CVD) deaths by 33% by 2030. Africa disproportionately bears the brunt of CVD burden and has one of the highest risks of dying from non-communicable diseases (NCDs) worldwide. There is currently an epide...miological transition on the continent, where NCDs is projected to outpace communicable diseases within the current decade. Unchecked increases in CVD risk factors have contributed to the growing burden of three major CVDs—hypertension, cardiomyopathies, and atherosclerotic diseasesleading to devastating rates of stroke and heart failure. The highest age standardized disability-adjusted life years (DALYs) due to hypertensive heart disease (HHD) were recorded in Africa. The contributory causes of heart failure are changing—whilst HHD and cardiomyopathies still dominate, ischemic heart disease is rapidly becoming a significant contributor, whilst rheumatic heart disease (RHD) has shown a gradual decline. In a continent where health systems are traditionally geared toward addressing communicable diseases, several gaps exist to adequately meet the growing demand imposed by CVDs. Among these, high-quality research to inform interventions, underfunded health systems with high out-of-pocket costs, limited accessibility and affordability of essential medicines, CVD preventive services, and skill shortages. Overall, the African continent progress toward a third reduction in premature mortality come 2030 is lagging behind. More can be done in the arena of effective policy implementation for risk factor reduction and CVD prevention, increasing health financing and focusing on strengthening primary health care services for prevention and treatment of CVDs, whilst ensuring availability and affordability of quality medicines. Further, investing in systematic country data collection and research outputs will improve the accuracy of the burden of disease data and inform policy adoption on interventions. This review summarizes the current CVD burden, important gaps in cardiovascular medicine in Africa, and further highlights priority areas where efforts could be intensified in the next decade with potential to improve the current rate of progress toward achieving a 33% reduction in CVD mortality. more

Heart Disease and Stroke Statistics—2022 Update: A Report From the American Heart Association

Tsao, C.W.; Aday, A.W.; Almarzooq, Z.I. et al. Circulation (2022) CC

The American Heart Association, in conjunction with the National Institutes of Health, annually reports the most up-to-date statistics related to heart disease, stroke, and cardiovascular risk factors, including core health behaviors (smoking, physical activity, diet, and weight) and health factors ... more